Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time

by Rundan Duan, Luise Goldmann, Richard Brandl, Michael Spannagl, Christian Weber, Christian Weber, Christian Weber, Wolfgang Siess, Wolfgang Siess, Philipp von Hundelshausen, Philipp von Hundelshausen
Published 2021-09-01

Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules.

by Bijan Raziorrouh, Malte Heeg, Peter Kurktschiev, Winfried Schraut, Reinhart Zachoval, Clemens Wendtner, Martin Wächtler, Michael Spannagl, Gerald Denk, Axel Ulsenheimer, Bertram Bengsch, Hanspeter Pircher, Helmut M Diepolder, Norbert H Grüner, Maria-Christina Jung
Published 2014-01-01